BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND CCND2, KIAK0002, 894, ENSG00000118971, P30279, MGC102758 AND Treatment
37 results:

  • 1. Development of an Automatic Rule-Based Algorithm for the Detection of Ovarian cancer Recurrence From Electronic Health Records.
    Lee S; Kim JH; Ha HI; Lim MC; Cho H
    JCO Clin Cancer Inform; 2024 Mar; 8():e2300150. PubMed ID: 38442323
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Efficacy and safety of VEGF/VEGFR inhibitors for platinum-resistant ovarian cancer: a systematic review and meta-analysis of randomized controlled trials.
    Huang D; Ke L; Cui H; Li S; Sun F
    BMC Womens Health; 2024 Jan; 24(1):34. PubMed ID: 38218775
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Evaluation of the anticancer effect of telomerase inhibitor BIBR1532 in anaplastic thyroid cancer in terms of apoptosis, migration and cell cycle.
    Turkmen E; Sogutlu F; Erdogan M; Biray Avci C
    Med Oncol; 2023 Jun; 40(7):196. PubMed ID: 37284891
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Comparison of Effectiveness as well as Advantages and Disadvantages of Different Dimensions of Hysterosalpingo-Contrast Sonography for Diagnosis of Lesions Associated with Female Infertility.
    Pei R
    Comput Math Methods Med; 2022; 2022():7508880. PubMed ID: 36164612
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Endoscopic versus Nonendoscopic Surgery for Resection of Craniopharyngiomas.
    Abiri A; Roman KM; Latif K; Goshtasbi K; Torabi SJ; Lehrich BM; Mohyeldin A; Hsu FPK; Kuan EC
    World Neurosurg; 2022 Nov; 167():e629-e638. PubMed ID: 36041722
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A novel parallel overlapping mode for complete ablation of large benign thyroid nodules in a single-session radiofrequency ablation.
    Wu T; Zheng B; Tan L; Yin T; Lian Y; Xu S; Ye J; Ren J
    Front Endocrinol (Lausanne); 2022; 13():915303. PubMed ID: 35992133
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Computed Tomography-based Radiomics Evaluation of Postoperative Local Recurrence of Pancreatic Ductal Adenocarcinoma.
    He M; Chen X; Wels M; Lades F; Li Y; Liu Z; Jin Z; Xue H
    Acad Radiol; 2023 Apr; 30(4):680-688. PubMed ID: 35906151
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Incidence of Vocal Cord Paralysis in Medullary Thyroid cancer.
    Drozdowski V; Martini D; Charous S
    Laryngoscope; 2023 Apr; 133(4):890-894. PubMed ID: 35833484
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. What Are the Characteristics of Papillary Thyroid Microcarcinoma Prone to High-Volume Lateral Lymph Node Metastasis? - An Analysis of 2981 Consecutive Cases.
    Gao L; Li X; Liu C; Liu R; Shi X; Ma L; Zhao H; Xia Y; Jiang Y
    J Invest Surg; 2022 Jul; 35(7):1519-1525. PubMed ID: 35610088
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Aggressive giant prolactinoma: a case report.
    Borhan MK; Tan FHS
    J Med Case Rep; 2022 Apr; 16(1):170. PubMed ID: 35488355
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Is adjuvant chemotherapy necessary for young women with early-stage epithelial ovarian cancer who have undergone fertility-sparing surgery?: a multicenter retrospective analysis.
    Ikeda Y; Yoshihara M; Yoshikawa N; Yokoi A; Tamauchi S; Nishino K; Niimi K; Kajiyama H
    BMC Womens Health; 2022 Mar; 22(1):80. PubMed ID: 35313889
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Risk factors impacting intra- and postoperative cerebrospinal fluid rhinorrhea on the endoscopic treatment of pituitary adenomas: A retrospective study of 250 patients.
    Wang M; Cai Y; Jiang Y; Peng Y
    Medicine (Baltimore); 2021 Dec; 100(49):e27781. PubMed ID: 34889229
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Clinical implication of xenotropic and polytropic retrovirus receptor 1 in papillary thyroid carcinoma.
    Zou H; Xiang C
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Feb; 50(1):90-96. PubMed ID: 34117845
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Circulating Tumor DNA-Based Testing and Actionable Findings in Patients with Advanced and Metastatic Pancreatic Adenocarcinoma.
    Botrus G; Kosirorek H; Sonbol MB; Kusne Y; Uson Junior PLS; Borad MJ; Ahn DH; Kasi PM; Drusbosky LM; Dada H; Surapaneni PK; Starr J; Ritter A; McMillan J; Wylie N; Mody K; Bekaii-Saab TS
    Oncologist; 2021 Jul; 26(7):569-578. PubMed ID: 33555095
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Integrative microRNA and gene expression analysis identifies new epigenetically regulated microRNAs mediating taxane resistance in ovarian cancer.
    Hassan MK; Waly AA; Elsayed W; Keshk S; Allam WR; El-Khamisy SF
    Sci Rep; 2021 Jan; 11(1):562. PubMed ID: 33436648
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Using Diffusion-Weighted MRI to Predict Central Lymph Node Metastasis in Papillary Thyroid Carcinoma: A Feasibility Study.
    Zhang H; Hu S; Wang X; Liu W; He J; Sun Z; Ge Y; Dou W
    Front Endocrinol (Lausanne); 2020; 11():326. PubMed ID: 32595598
    [No Abstract]    [Full Text] [Related]  

  • 17. Early Diagnosis of Medullary Thyroid cancer: Are Calcitonin Stimulation Tests Still Indicated in the Era of Highly Sensitive Calcitonin Immunoassays?
    Niederle MB; Scheuba C; Riss P; Selberherr A; Koperek O; Niederle B
    Thyroid; 2020 Jul; 30(7):974-984. PubMed ID: 32056502
    [No Abstract]    [Full Text] [Related]  

  • 18. Comparing Standard Performance and Outcome Measures in Hospitalized Pituitary Tumor Patients with Secretory versus Nonsecretory Tumors.
    Vlasak AL; Shin DH; Kubilis PS; Roper SN; Karachi A; Hoh BL; Rahman M
    World Neurosurg; 2020 Mar; 135():e510-e519. PubMed ID: 31863896
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Identification of Important Invasion-Related Genes in Non-functional Pituitary Adenomas.
    Joshi H; Vastrad B; Vastrad C
    J Mol Neurosci; 2019 Aug; 68(4):565-589. PubMed ID: 30982163
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers.
    Singhi AD; George B; Greenbowe JR; Chung J; Suh J; Maitra A; Klempner SJ; Hendifar A; Milind JM; Golan T; Brand RE; Zureikat AH; Roy S; Schrock AB; Miller VA; Ross JS; Ali SM; Bahary N
    Gastroenterology; 2019 Jun; 156(8):2242-2253.e4. PubMed ID: 30836094
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.